Tirzepatide 83516-0245
Product NDC
83516-0245- Manufacturer
- Resilience Us, Llc
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- December 27, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tirzepatide | 12.5 mg/.5mL |
Packaging Options(1)
96 TRAY in 1 CASE (83516-0245-1) / 45 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE